IPI-504 (tanespimycin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPI-504 (tanespimycin), covering 2010-02-03 to 2010-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer [Phase 1, Phase 2]